Letter

Postnatal economic burden of limited karyotyping

BMJ 2006; 332 doi: 10.1136/bmj.332.7542.668-c (Published 16 March 2006)
Cite this as: BMJ 2006;332:668.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Suneel B Bhat, pre-medical student (sbhat@princeton.edu),
  2. Sanjay B Bhat, collaborator,
  3. Jessica Stevens, chief paediatric resident
  1. Princeton University, Princeton, NJ 08544, USA
  2. University of Medicine and Dentistry of New Jersey, New Jersey Medical School

    EDITOR—Chitty et al suggest a strategy to identify chromosomal abnormalities that relies on quantitative fluorescent polymerase chain reaction (qf-PCR) and full karyotyping only in cases of fetal nuchal translucency thickness > 4 mm, as opposed to full karyotyping of all chorionic villous samples.1 Eliminating double testing results in an upfront economic savings …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular